MYCN and neuroblastoma: Accordingly, the FAM13A-AS lower expression was associated with worse prognosis for NB patients (Group A, Fig. S6a), FAM13A expression was higher in MYCN-amplified cells (Fig. S6b) of NB patients with poor prognosis (Fig. S6c, Analysis of KOCAK NB database in R2 database).